H. pylori Infection and Colorectal Cancers by Anatomical Locations.

Dao Viet Hang,Tran Hieu Hoc,Ngoan Tran Le,Tran Que Son,Le Hong Phuoc,Dinh Thi Minh

doi:10.31557/apjcp.2020.21.8.2431

Abstract

Background: H. pylori infection may play a role in the development of colorectal cancers (CRC). We aimed to examine the association between H. pylori infection and the risk of CRC by anatomical locations. Methods:We conducted a case-control study on 91 incidence cases of CRC and 224 hospital controls. CRC was determined by histopathological examinations. H. pylori IgG antibody in serum was tested. We collected data on the diet, nutrition, and lifestyle by the validated semi-quantitative food frequency and demographic lifestyle questionnaire. The odds ratio and 95% confidence interval (OR (95%CI) were estimated for CRC and its subgroups. Results:Overall 54.95% of CRC cases and 42.41% of the controls were H. pylori-seropositive, OR (95%CI): 1.56 (0.88, 2.74), p for trend=0.115. Positive dose-response association in quartiles, highest vs lowest, was observed for total CRC, OR (95%CI): 2.14 (1.00, 4.58), p for trend=0.049, for proximal colon, OR (95%CI): 1.52 (0.37, 6.25), p for trend=0.571), and for distal colon and rectum cancers combined, OR (95%CI): 2.38 (1.03, 5.50), p for trend=0.039. Conclusions:There is a positive association between H. pylori and colorectal cancers, especially distal colon and rectum cancers combined, but additional research is needed to determine the underlying mechanism of chronic H. pylori infection-induced CRC in humans.

Highlights

For many decades, the standard triple therapy to eradicate H. pylori infection and prevent gastric cancer, including a proton pump inhibitor combined with clarithromycin and amoxicillin or metronidazole, has been recommended in the Vietnamese and other populations for both children and adults (Nguyen et al, 2008; Papastergiou et al, 2014)
H. pylori infection may play a role in the development of colorectal cancers (CRC)
We aimed to examine the association between H. pylori infection and the risk of CRC by anatomical locations

Summary

Introduction

The standard triple therapy to eradicate H. pylori infection and prevent gastric cancer, including a proton pump inhibitor combined with clarithromycin and amoxicillin or metronidazole, has been recommended in the Vietnamese and other populations for both children and adults (Nguyen et al, 2008; Papastergiou et al, 2014). Antibiotic use predicts an increased risk of cancers (Kilkkinen et al, 2008). Oral use of antibiotics associated with the increased risk of colon cancer in the. We aimed to examine the association between H. pylori infection and the risk of CRC by anatomical locations. Positive dose-response association in quartiles, highest vs lowest, was observed for total CRC, OR (95%CI): 2.14 (1.00, 4.58), p for trend=0.049, for proximal colon, OR (95%CI): 1.52 (0.37, 6.25), p for trend=0.571), and for distal colon and rectum cancers combined, OR (95%CI): 2.38 (1.03, 5.50), p for trend=0.039. Conclusions: There is a positive association between H. pylori and colorectal cancers, especially distal colon and rectum cancers combined, but additional research is needed to determine the underlying mechanism of chronic H. pylori infection-induced CRC in humans

Objectives

Methods

Results